Abstract
Taurine (2-aminoethanesulfonate) is a ubiquitous β-amino acid found in a very high concentration in excitable tissue. One of its most important functions is its conjugation with uridine located in the wobble position of tRNALeu(UUR). Because the wobble modification stabilizes the UG base pairing, it facilitates the decoding of UUG codons. Consequently, taurine deficiency, which reduces the wobble modification, decreases the synthesis of proteins whose mRNA has a high UUG codon content. The synthesis of one such protein, ND6, plunges 60% after a 50% decline in taurine content. Because ND6 is a subunit of respiratory chain complex I, taurine depletion also leads to a decline in the activity of the electron transport chain. A similar sequence of events occurs in the mitochondrial disease, MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes). The initial event in most MELAS patients is the appearance of one mutation in tRNALeu(UUR), which in turn blocks the taurinomethyl modification of the wobble nucleotide. As a result, the synthesis of ND6 and other UUG-dependent proteins falls. As respiratory function declines, the generation of ATP is compromised and in some cases the mitochondria begin to produce oxidants. Because mutations in tRNALeu(UUR) trigger multiple events, the identification of which event causes mitochondrial dysfunction has been challenging. The taurine-deficient model has aided in the identification of at least one pathological pathway that contributes to the development of the MELAS disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kleist-Retzow JC, Schauseil-Zipf J, Michalk DV, et al. Mitochondrial diseases: an expanding spectrum of disorders and affected genes. Exp Physiol. 2003;88:155–66.
Chomyn A, Enriquez JA, Micol V, et al. The mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like syndrome-associated human mitochondrial tRNALeu (UUR) mutation causes aminoacylation deficiency and concomitant reduced association of mRNA with ribosomes. J Biol Chem. 2000;275:19198–209.
Sohm B, Sissler M, Park H, et al. Recognition of human mitochondrial tRNALeu (UUR) by its cognate leucyl-tRNA synthetase. J Mol Biol. 2004;339:17–29.
Tsutsui H, Kinugawa S, Matsushima S. Mitochondrial oxidative stress and dysfunction in myocardial remodeling. Cardiovasc Res. 2009;81:449–56.
Anan R, Nakagawa M, Higuchi I, et al. Cardiac involvement in mitochondrial diseases: A study on 17 patients with documented mitochondrial DNA defects. Circulation. 1995;91:955–61.
Casademont J, Miro O. Electron transport chain defects in heart failure. Heart Fail Rev. 2002;7:131–9.
Limongelli G, Tome-Esteban M, Dejthevaporn C, et al. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail. 2010;12:114–21.
Vydt TCG, de Coo RFM, Soliman OII, et al. Cardiac involvement in adults with m.3243A > G MELAS gene mutation. Am J Cardiol. 2007;99:264–9.
Goto YI, Nonaka I, Horai S. A mutation in the tRNALeu (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651–3.
Goto YI, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta. 1991;1097:238–40.
Finsterer J. Mitochondriopathies. Eur J Neurol. 2004;11:163–86.
Kirino Y, Goto YI, Campos Y, et al. Specific correlation between the wobble modification deficiency in mutant tRNAs and the clinical features of a human mitochondrial disease. Proc Natl Acad Sci USA. 2005;102:7127–32.
King MP, Koga Y, Davidson M, et al. Defects in mitochondrial protein synthesis and respiratory chain activity segregate with the tRNALeu (UUR) mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like syndrome. Mol Cell Biol. 1992;12:480–90.
Li R, Guan MX. Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunction due to the tRNALeu (UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol Cell Biol. 2010;30:2147–54.
Mariotti C, Tiranti V, Carrara F, et al. Defective respiratory capacity and mitochondrial protein synthesis in transformant cybrids harbor the tRNALeu (UUR) mutation associated with maternally inherited myopathy and cardiomyopathy. J Clin Invest. 1994;93:1102–7.
Ikawa M, Kawai Y, Arakawa K, et al. Evaluation of respiratory chain failure in mitochondrial cardiomyopathy by assessments of 99mTc-MIBI washout and 123I-BMIPP/99mTc-MIBI mismatch. Mitochondrion. 2007;7:164–70.
Hess JF, Parisi MA, Bennett JL, et al. Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1991;351:236–9.
Helm M, Florentz C, Chomyn A, et al. Search for differences in post-transcriptional modification patterns of mitochondrial DNA-encoded wild-type and mutant human tRNALys and tRNALeu (UUR). Nucleic Acid Res. 1999;27:756–63.
Park H, Davidson E, King MP. The pathogenic A3243G mutation in human mitochondrial tRNALeu (UUR) decreases the efficiency of aminoacylation. Biochemistry. 2003;42:958–64.
Hao R, Yao YN, Zheng YG, et al. Reduction of mitochondrial tRNALeu (UUR) aminoacylation by some MELAS-associated mutations. FEBS Lett. 2004;578:135–9.
Lofgren DJ, Thompson LH. Relationship between histidyl-tRNA level and protein synthesis rate in wild-type and mutant Chinese hamster ovary cells. J Cell Physiol. 1979;99:303–12.
Yasukawa T, Suzuki T, Ueda T, et al. Modification defect at anticodon Wobble nucleotide of mitochondrial tRNALeu (UUR) pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes. J Biol Chem. 2000;275:4251–7.
Takai K, Okumura S, Hosono K, et al. A single uridine modification at the wobble position of an artificial tRNA enhances wobbling in an Escherichia coli cell-free translation system. FEBS Lett. 1999;447:1–4.
Weixlbaumer A, Murphy IV FV, Dziergowska A, et al. Mechanism for expanding the decoding capacity of transfer RNAs by modification of uridines. Nat Struct Mol Biol. 2007;14:498–502.
Kurata S, Weixlbaumer A, Ohtsuki T, et al. Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U-G wobble pairing during decoding. J Biol Chem. 2008;283:18801–11.
Kirino Y, Yasukawa T, Oha S, et al. Codon-specific translation defect caused by wobble modification deficiency in mutant tRNA from a human mitochondrial disease. Proc Natl Acad Sci USA. 2004;101:15070–5.
Hayashi J, Ohta S, Takai D, et al. Accumulation of mtDNA with a mutation at position 3271 in tRNALeu (UUR) gene introduced from a MELAS patient to HeLa cells lacking mtDNA results in progressive inhibition of mitochondrial respiratory function. Biochem Biophys Res Commun. 1993;197:1049–55.
Huxtable RJ. Physiological actions of taurine. Physiol Rev. 1992;72:101–63.
Pion PD, Kittleson MD, Rogers QR, et al. Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy. Science. 1987;237:764–8.
Eley DW, Lake N, ter Keurs HEDJ. Taurine depletion and excitation-contraction coupling in rat myocardium. Circ Res. 1994;74:11210–19.
Ito T, Kimura Y, Uozumi Y, et al. Taurine depletion caused by knocking out the taurine transporter gene leads to a cardiomyopathy and cardiac atrophy. J Mol Cell Cardiol. 2008;44:927–37.
Pastukh V, Ricci C, Solodushko V, et al. Contribution of PI 3-kinase/Akt survival pathway toward osmotic preconditioning. Mol Cell Biochem. 2005;269:59–67.
Sasarman F, Antonicka H, Shoubridge EA. The A3243G tRNALeu (UUR) mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2. Hum Mol Genet. 2008;17:3697–707.
Ricci C, Pastukh V, Leonard J, et al. Mitochondrial DNA damage triggers mitochondrial superoxide generation and apoptosis. Am J Physiol. 2008;294:C413–22.
Lenaz G, Baracca A, Carelli V, et al. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. Biochim Biophys Acta. 2004;1658:89–94.
Acknowledgments
The present study was supported with a grant from the American Heart Association.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Schaffer, S.W., Jong, C.J. (2011). MELAS Syndrome: Mediated by Impaired Taurinomethyluridine Synthesis. In: Ostadal, B., Nagano, M., Dhalla, N. (eds) Genes and Cardiovascular Function. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-7207-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7207-1_10
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-7206-4
Online ISBN: 978-1-4419-7207-1
eBook Packages: MedicineMedicine (R0)